Source:http://linkedlifedata.com/resource/lhgdn/association:4544
| Predicate | Object |
|---|---|
| lhgdn:found_in | |
| lhgdn:geneRifSource |
a carrier of the founder CDKN2A [p.Leu113Leu; p.Pro114Ser]mutation as well as two MC1R moderate-risk variants, [p.Arg151Cys (+) p.Arg163Gln]developed 22 primary melanomas in the 3 years that followed initiation of levodopa therapy for Parkinson?s disease
|
| lhgdn:mesh_code |
D008545
|
| lhgdn:associationIdType | |
| lhgdn:umls_code |